• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Cyveillance Outlines Best Practices for Combating Illegal Online Pharmaceutical Distribution; New Research Provides Counter-Measures for Limiting Exposure and Risk

Posted on: Monday, 19 June 2006, 12:00 CDT

Cyveillance, the leading provider of online risk monitoring and management solutions, today announced the availability of "Combating Illegal Online Distribution of Pharmaceuticals: Best Practices for the Pharmaceutical Industry," a new research paper available at: www.cyveillance.com/pharma.

The Wall Street Journal reports that illegal sales cost the pharmaceutical industry about $46 billion a year, to say nothing of the serious, often deadly consequences of ingesting uncontrolled and counterfeit substances. As part of Cyveillance's mission to educate users on how to identify and address online threats, the company is providing companies with the information and tools required to reduce the impact to their business, while also addressing the larger public health issue posed by counterfeit drugs and medicine obtained outside a doctor's prescription.

"The distribution of illegal drugs online not only impacts Pharmaceutical companies' revenues and brand reputation but also poses a threat to public health," said Todd Bransford, vice president of marketing at Cyveillance. "To combat these risks, public and private sectors need to work together and take proactive steps, and Cyveillance is dedicated to providing the tools and information required to eliminate these threats."

The most effective countermeasures to illegal online distribution of pharmaceuticals require collaboration among brand managers, online commerce managers, legal departments, investigators, law enforcement officials, and even research and development departments. A successful approach involves comprehensive and continuous online risk monitoring, providing all parties with relevant and actionable intelligence in a secure environment where they can easily share and cooperate across departmental lines. In this whitepaper, Cyveillance outlines a proven 360-degree process that incorporates such collaborative strategies to help pharmaceutical companies protect their brands, revenues and consumer trust.

Cyveillance provides readers with best practices on how to:

-- Leverage the power of automated comprehensive online monitoring;

-- Build effective cross-functional collaboration between top management, corporate counsel, compliance officers, marketing executives, investigators and security officers; and

-- Close the loop by teaming with law enforcement agencies and other authorities to stop the distribution of illegal drugs.

To learn more about best practices for combating the illegal distribution of illegal pharmaceuticals, go to: http://www.cyveillance.com/pharma.

About Cyveillance:

Cyveillance provides online risk monitoring and management solutions to Global 2000 organizations. The company comprehensively monitors the Internet using patented technology to deliver early warning of risks to information, infrastructure and individuals. Armed with this actionable intelligence and Cyveillance's immediate corrective response capability, chief security officers can proactively protect their company's reputation, revenues and customer trust. Cyveillance counts over half of the Fortune 50 and three quarters of the top Fortune 500 companies in the financial services, pharmaceutical, energy, and technology industries as clients.

Source: Business Wire

More News in this Category